Amifostine: chemotherapeutic and radiotherapeutic protective effects.
about
H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cellsPhase I study of fotemustine in pediatric patients with refractory brain tumors.Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.Systematic review of amifostine for the management of oral mucositis in cancer patients.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larPodophyllum hexandrum as a potential botanical supplement for the medical management of nuclear and radiological emergencies (NREs) and free radical-mediated ailments: leads from in vitro/in vivo radioprotective efficacy evaluation.What are the challenges in pediatric oncology?Xanthoria elegans (Link) (lichen) extract counteracts DNA damage and oxidative stress of mitomycin C in human lymphocytes.Protective effect of melatonin against mitomycin C-induced genotoxic damage in peripheral blood of rats.Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity.Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cells.Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats.The effect of amifostine on bacterial translocation after radiation ınduced acute enteritis.Effects of potential dietary inhibitors of endogenous DNA damage on mutagenesis and lipid peroxidation in lacZ mice.
P2860
Q28475930-6C502565-3F13-4EE1-8A76-26D46AE41B20Q33344136-51369AE5-F548-41C9-8337-3307BD893272Q37437083-993B051E-210F-4DF4-8DA7-894087AC0319Q37731433-6E7D84CA-2CE0-4966-A4E4-A6DF504EB304Q38038330-4AB09CAA-36CD-4CBD-8CF6-3C61B0AAD67EQ38050986-925055D9-D3E3-4C8D-A116-FE3273AAA145Q38665691-A357E7FC-A2CD-4545-9D90-BE03BD681743Q39897015-F5B418EA-4355-400F-AF55-A06D7FFF861BQ40636885-EDD36792-6AF3-414E-98E6-B7B0E54A2285Q41513770-FABBF5D7-DAFB-460B-8CF7-51AC00354303Q41791273-53AE659A-CE74-4814-AB8B-C677FD1E90ADQ42130904-CA3D3FDC-A0F7-4302-B11C-08658BBD18A7Q43243995-8F1A4C80-DB7F-4EB0-9FEA-EAC6F06E4573Q44711962-4D1CDE04-7A41-40C7-BA2C-A126682422A9Q50068665-CD017C1A-7EFC-4B1A-852C-8F9ECC2A91FDQ50911977-0B5FC431-17C5-450F-947D-3EC162322B11Q53287325-49DF945D-CA36-4744-A8BA-20987487181C
P2860
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@ast
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@en
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@nl
type
label
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@ast
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@en
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@nl
prefLabel
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@ast
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@en
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@nl
P2860
P356
P1476
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
@en
P2093
P2860
P304
P356
10.1517/14656566.2.3.479
P407
P577
2001-03-01T00:00:00Z